featured
Brentuximab Vedotin, Nivolumab, Doxorubicin, and Dacarbazine for Advanced-Stage Classical Hodgkin Lymphoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Brentuximab Vedotin, Nivolumab, Doxorubicin, and Dacarbazine for Advanced-Stage Classical Hodgkin Lymphoma
Blood 2024 Dec 02;[EPub Ahead of Print], HJ Lee, R Ramchandren, J Friedman, JM Melear, IW Flinn, JM Burke, Y Linhares, PA Gonzales, M Peterson, M Raval, R Chintapatla, TA Feldman, HA Yimer, M Islas-Ohlmayer, A Patel, L Metheny, A Dean, V Rana, MD Gandhi, JS Renshaw, L Ho, MA Fanale, W Guo, CA YasenchakFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.